MIR210: A Potential Drug Target Or Biomarker (G406992)
MIR210: A Potential Drug Target Or Biomarker
MIR210 (hsa-miR-210-5p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. MIR210 is a microRNA (miRNA) that is expressed in various tissues and cells throughout the body. It is a part of a family of miRNAs that have been shown to play important roles in cellular processes such as cell growth, differentiation, and metabolism.
One of the unique features of MIR210 is its expression pattern. MIR210 is primarily expressed in the brain, but is also found in other tissues such as muscle, heart, and liver. It is also shown to be highly expressed in cancer tissues, which could make it an attractive target for cancer therapies.
In addition to its expression pattern, MIR210 has also been shown to play a role in cellular processes. For example, studies have shown that MIR210 can interact with the protein p53, which is a well-known tumor suppressor gene. This interaction suggests that MIR210 may be involved in regulating the activity of p53, which could be a potential target for cancer therapies.
Another potential mechanism by which MIR210 may be involved in cancer is its role in cell signaling pathways. MIR210 has been shown to be involved in several signaling pathways, including the TGF-β pathway and the PI3K/Akt pathway. These pathways are involved in cellular processes such as cell growth, differentiation, and survival, and are often disrupted in cancer. Therefore, targeting MIR210 may be a promising approach for cancer therapies.
MIR210 has also been shown to be involved in the regulation of gene expression. Studies have shown that MIR210 can interact with the protein miRNA-1 (miR-1), which is a well-known regulator of gene expression. This interaction suggests that MIR210 may be involved in the regulation of miR-1 activity, which could be a potential target for technologies such as RNA interference (RNAi) therapies.
In addition to its potential role in cancer, MIR210 may also be involved in other cellular processes. For example, it has been shown to be involved in the regulation of cell adhesion, which is important for the development and maintenance of tissues and organs. MIR210 has also been shown to be involved in the regulation of cell signaling pathways, such as the Wnt pathway, which is involved in the development and maintenance of tissues and organs.
Given its involvement in several cellular processes, MIR210 may be an attractive target for drug development. Studies have shown that MIR210 can be effectively targeted with small molecules, such as RNA interference (RNAi) agents. In addition, MIR210 may also be a good candidate for vaccines, as it is expressed in a variety of tissues and cells throughout the body.
In conclusion, MIR210 is a non-coding RNA molecule that has been shown to play important roles in cellular processes such as cell growth, differentiation, and metabolism. Its expression pattern and interactions with other proteins suggest that MIR210 may be involved in several cellular processes, including the regulation of p53 activity and the regulation of gene expression. In addition, MIR210 may be an attractive target for drug development due to its effectiveness with small molecules and potential for vaccines. Further research is needed to fully understand the role of MIR210 in cellular processes and its potential as a drug target or biomarker.
Protein Name: MicroRNA 210
The "MIR210 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR210 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR210HG | MIR211 | MIR2110 | MIR2113 | MIR2114 | MIR2115 | MIR2116 | MIR2117 | MIR212 | MIR214 | MIR215 | MIR216A | MIR216B | MIR217 | MIR217HG | MIR218-1 | MIR218-2 | MIR219A1 | MIR219A2 | MIR219B | MIR22 | MIR221 | MIR222 | MIR223 | MIR224 | MIR2276 | MIR2277 | MIR2278 | MIR22HG | MIR2355 | MIR2392 | MIR23A | MIR23AHG | MIR23B | MIR23C | MIR24-1 | MIR24-2 | MIR2467 | MIR25 | MIR2681 | MIR2682 | MIR26A1 | MIR26A2 | MIR26B | MIR27A | MIR27B | MIR28 | MIR2861 | MIR2909 | MIR296 | MIR297 | MIR298 | MIR299 | MIR29A | MIR29B1 | MIR29B2 | MIR29B2CHG | MIR29C | MIR300 | MIR301A | MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128
